At a glance
ClinicalIndex Comparison RecordN/ACompleted· 22 enrolled
Drug / intervention
JUUL electronic cigarette +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessment of Two New Electronic Cigarettes in Cigarette Smokers
In Brief
A clinical study evaluating JUUL electronic cigarette, IQOS electronic cigarette, and 1 other intervention for Electronic Cigarettes. Completed, enrolled 22 participants across 1 site.
Detailed Summary
The purpose of this study is to determine differences in nicotine delivery, user behavior, subjective effects, and physiological effects, when cigarette smokers use an two new electronic cigarette devices (JUUL and IQOS) relative to their using their own brand of cigarettes.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsElectronic Cigarettes
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedFeb 2018
Enrollment StartMar 2018
Primary CompletionAug 2019
TodayJul 2026
First PostedFeb 19, 2018
Enrollment StartMar 3, 2018
Primary CompletionAug 16, 2019
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 8.4 years ago
Interventions
JUUL electronic cigaretteother
Effects of JUUL electronic cigarette use.
IQOS electronic cigaretteother
Effects of IQOS electronic cigarette use.
Own Brand cigaretteother
Effects of own brand cigarette use.